Hillsdale Investment Management’s Akero Therapeutics AKRO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-100	Closed	-$5.06K	–	561
2023 Q3	$5.06K	Buy	100 +20	+25%	+$1.01K	﹤0.01%	512
2023 Q2	$3.74K	Sell	80 -17,820	-100%	-$832K	﹤0.01%	481
2023 Q1	$685K	Buy	+17,900	New	+$685K	0.06%	244